My bookmarksSign up free

Commission Implementing Regulation (EU) 2015/404 of 11 March 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb Text with EEA relevance

Commission Implementing Regulation (EU) 2015/404 of 11 March 2015 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb Text with EEA relevance

Implementing Regulation (EU) 2015/404 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 145, captan, the date of β€˜30 September 2017’ is replaced by β€˜31Β July 2018’; (2) in the sixth column, expiration of approval, of row 146, folpet, the date of β€˜30 September 2017’ is replaced by β€˜31Β July 2018’; (3) in the sixth column, expiration of approval, of row 147, formetanate, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (4) in the sixth column, expiration of approval, of row 148, methiocarb, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (5) in the sixth column, expiration of approval, of row 149, dimethoate, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (6) in the sixth column, expiration of approval, of row 150, dimethomorph, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (7) in the sixth column, expiration of approval, of row 151, glufosinate, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (8) in the sixth column, expiration of approval, of row 152, metribuzin, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (9) in the sixth column, expiration of approval, of row 153, phosmet, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (10) in the sixth column, expiration of approval, of row 154, propamocarb, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (11) in the sixth column, expiration of approval, of row 155, ethoprophos, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (12) in the sixth column, expiration of approval, of row 156, pirimiphos-methyl, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (13) in the sixth column, expiration of approval, of row 157, fipronil, the date of β€˜30 September 2017’ is replaced by β€˜31 July 2018’; (14) in the sixth column, expiration of approval, of row 158, beflubutamid, the date of β€˜30 November 2017’ is replaced by β€˜31 July 2018’.

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next